Gam Holding Ag Esperion Therapeutics, Inc. Transaction History

Gam Holding Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$19.4 - $28.71 $1.37 Million - $2.03 Million	-70,700 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$25.12 - $36.89 $1.78 Million - $2.61 Million	70,700 New	70,700 $1.98 Million
Q4 2020 Feb 10, 2021	SELL	$24.2 - $35.76 $1.71 Million - $2.53 Million	-70,700 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$27.44 - $73.84 $474,712 - $1.28 Million	-17,300 Reduced 19.66%	70,700 $2.23 Million
Q4 2018 Feb 08, 2019	SELL	$36.99 - $59.11 $1.69 Million - $2.71 Million	-45,800 Reduced 34.23%	88,000 $4.05 Million
Q2 2018 Aug 09, 2018	SELL	$36.2 - $76.4 $2.35 Million - $4.95 Million	-64,800 Reduced 32.63%	133,800 $5.24 Million
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $1.74 Million - $2.13 Million	-26,400 Reduced 11.73%	198,600 $14.4 Million
Q2 2017 Aug 07, 2017	BUY	N/A	225,000	225,000 $10.4 Million

211

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.